Vincerx Pharma Inc Stock Ownership - Who owns Vincerx Pharma?

Insider buying vs selling

Have Vincerx Pharma Inc insiders been buying or selling?
Alexander A. SeelenbergerOfficer2023-08-1110,500$0.95
Ahmed Md HamdyPresident and Chief Operations Officer2023-08-105,400$0.96
Raquel E. IzumiPresident and Chief Operations Officer2023-08-103,440$0.93
Tom C. ThomasPresident and Chief Operations Officer2023-08-105,000$0.95
Ahmed Md HamdyPresident and Chief Operations Officer2023-08-0916,900$0.95
Raquel E. IzumiPresident and Chief Operations Officer2023-08-0913,036$0.90

1 of 1

VINC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VINC insiders and whales buy or sell their stock.

VINC Shareholders

What type of owners hold Vincerx Pharma Inc stock?
Rubric Capital Management LP7.13%2,107,000$1.27MInsider
Ahmed Md Hamdy6.36%1,878,679$1.13MInsider
Raquel E. Izumi6.05%1,787,187$1.07MInsider
Sage Rhino Capital LLC5.77%1,703,413$1.02MInstitution
Michael Yehuda Rice5.76%1,701,000$1.02MInsider
Andrew I. McDonald5.54%1,636,942$983.80kInsider
John C. Byrd5.48%1,618,199$972.54kInsider
Octagon Capital Advisors LP3.39%1,000,000$601.00kInstitution
Point72 Asset Management LP3.23%954,827$573.85kInstitution
Rock Springs Capital Management LP3.02%891,719$535.92kInstitution

1 of 3

VINC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VINC28.70%38.94%Net Buying
LUMO16.51%83.49%Net BuyingNet Buying
SYBX5.74%94.26%Net SellingNet Selling
NRXS1.12%39.67%Net Buying

Vincerx Pharma Stock Ownership FAQ

Who owns Vincerx Pharma?

Vincerx Pharma (NASDAQ: VINC) is owned by 28.70% institutional shareholders, 38.94% Vincerx Pharma insiders, and 32.36% retail investors. Rubric Capital Management LP is the largest individual Vincerx Pharma shareholder, owning 2.11M shares representing 7.13% of the company. Rubric Capital Management LP's Vincerx Pharma shares are currently valued at $1.27M.

If you're new to stock investing, here's how to buy Vincerx Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.